Skip to main content
. Author manuscript; available in PMC: 2011 Nov 16.
Published in final edited form as: Biochemistry. 2010 Oct 25;49(45):9866–9873. doi: 10.1021/bi101412m

Figure 1.

Figure 1

A and B, respectively: SEC of TLP and plasma before (grey fill) and after (black curve) incubation with rSOF. C: Expansion of the SEC profile to show separation of VLDL and CERM in rSOF-treated plasma. Dashed line, plasma VLDL; white line ,CERM, the difference between plasma and rSOF-treated plasma. D and E: Immunoblots of fractions 4 and 5 probed with anti apos E and A-II respectively.